Login
Super Investors Atlas Venture Associates IX, LLC
AV

Atlas Venture Associates IX, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$631M
Positions
8
Quarter ended
December 31, 2020
Filed
February 11, 2021

Holdings

As reported for the quarter ended December 31, 2020. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
S Skillz Inc 73.8% Unchanged 23,284,403 $466M
Intellia Therapeutics Inc 13.9% Unchanged 1,615,321 $87.9M
SO Surface Oncology Inc 4.3% Unchanged 2,945,453 $27.2M
Spero Therapeutics Inc 4.2% Unchanged 1,376,968 $26.7M
Cogent Biosciences Inc 1.6% Unchanged 916,196 $10.3M
Snap Inc 1.2% Unchanged 150,160 $7.52M
Synlogic Inc 0.9% Unchanged 2,651,963 $5.73M
0 0 0.0% Unchanged 0 —

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support